The exposure to fine particulate matter (PM) in reinforced concrete production.
C-Path’s TRxA launches 2024 grants to boost next-gen therapeutics
Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced its 2024 global Request for Proposals for its Breakthrough Research and Innovation in Drug Development